Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $11.0750 (-1.29%) ($11.0750 - $11.0750) on Mon. Dec. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.38% (three month average) | RSI | 69 | Latest Price | $11.0750(-1.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.9% a day on average for past five trading days. | Weekly Trend | FOLD advances 1.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(72%) IBB(71%) TAN(69%) XLB(68%) VT(67%) | Factors Impacting FOLD price | FOLD will decline at least -1.69% in a week (0% probabilities). VIXM(-19%) XLE(-16%) UUP(-12%) URA(-10%) BNDX(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.69% (StdDev 3.38%) | Hourly BBV | -0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.92(1.42%) | 10 Day Moving Average | $10.83(2.26%) | 20 Day Moving Average | $10.8(2.55%) | To recent high | -17% | To recent low | 11.1% | Market Cap | $2.86b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |